If your ophthalmic range needs a fixed-dose antibiotic-plus-steroid combination, finding a moxifloxacin eye drops manufacturer that can fill it under sterile conditions is the real bottleneck — not the formula. Moxifloxacin paired with loteprednol is a sterile ophthalmic product, which means the supplier you choose has to clear a far higher facility bar than a tablet or syrup maker. This page is written for distributors, ophthalmic franchise partners and brands sourcing this combination for their own label. It covers what the format involves, how dropper bottles are packed, MOQ and supply models, and how to raise an enquiry with Biozia Lifesciences, who manufacture this drop as Visiquin-LP.
Key takeaways (TL;DR)
- Moxifloxacin + Loteprednol is a sterile ophthalmic combination, so it can only be filled on aseptic ophthalmic lines — a much smaller pool of capable makers.
- It ships in a multi-dose dropper bottle (LDPE/sterile fill), so the packaging brief covers bottle size, nozzle, seal and carton, not just the liquid.
- You can source it three ways: third-party (your brand), ophthalmic PCD franchise (monopoly territory), or contract manufacturing.
- What you provide is commercial paperwork — Drug License, GST and your brand artwork; the maker holds the sterile production licence.
- Biozia Lifesciences makes this combination as Visiquin-LP and supplies it pan-India from its WHO-GMP, ISO-certified site in Yamunanagar, Haryana.
What this combination drop actually is, for a buyer
From a sourcing point of view, the value of pairing moxifloxacin with loteprednol is that it puts two actives a clinic would otherwise prescribe separately into one bottle — an antibiotic component and a corticosteroid component in a single fixed-dose ophthalmic preparation. For your catalogue that means one SKU instead of two, a tidier prescription line for the ophthalmologists your distributors call on, and a product that sits in the steroid-antibiotic eye-drop segment many ranges leave empty. We are describing the commercial role of the SKU here, not how it should be used clinically — that sits with the prescriber. What matters when you shortlist a supplier is whether they can fill it sterile, consistently, batch after batch.
Why a sterile ophthalmic line is the deciding factor
An eye drop goes onto the surface of the eye, so it is held to sterility standards closer to an injectable than to an oral liquid. That is the single biggest filter when you choose a supplier. Many contract makers who can produce tablets, capsules and syrups simply do not have aseptic ophthalmic filling, because the cleanrooms, validated sterilisation and environmental controls behind it are expensive and slow to build. A maker who already runs a proven eye-drop line is genuinely hard to replace once you are on shelf — so treat sterile ophthalmic capability as your first qualifying question, well before you discuss rates.
Biozia Lifesciences sits in that smaller group: alongside its 250+ formulations across nine dosage forms, it runs sterile lines covering injections, IV infusions and eye drops — the combination most general manufacturers cannot offer under one roof.
Dropper-bottle packaging: the brief you’ll be asked for
With a sterile drop, a large part of the conversation is packaging, because the container is part of the sterile system. When you enquire, expect to specify roughly the following:
| Packaging element | What you decide |
|---|---|
| Fill volume | Common ophthalmic dropper sizes such as 3 ml, 5 ml or 10 ml |
| Bottle & nozzle | LDPE dropper bottle with a controlled-drop nozzle and tamper-evident cap |
| Seal | Sterile fill with a tamper-evident closure for transit and shelf integrity |
| Label & carton | Mono-carton per bottle with your brand artwork and a leaflet where required |
| Shipper | Outer carton count and configuration for your distribution lots |
Exact sizes and pack options depend on the maker’s validated formats — confirm what’s available before you finalise artwork.
Three ways to source it
How you buy this drop depends on whether you want your own label, a protected selling territory, or a pure manufacturing arrangement.
Third-party (your own brand)
The maker fills the drop to your specification and your brand name. You keep the customers and the margin; they handle sterile production, QC and packing. Good fit if you already have distribution and want to add this SKU under a name you own.
Ophthalmic PCD franchise (monopoly)
You take this product — and often a wider eye-care range — as a monopoly franchise for a defined territory, with the company’s existing brands and promotional support. This suits field-driven distributors who want an exclusive ophthalmic line to call on clinics with.
Contract / loan-licence manufacturing
For larger players, the drop is produced to your dossier and volumes, with batch sizes and specifications agreed up front. This is the route when you are scaling and want predictable, repeatable sterile supply.
What to send when you enquire, and what comes back
To get an accurate quote rather than a ballpark, give the maker enough to scope your order in one pass:
- The product & pack — moxifloxacin + loteprednol drop, your preferred fill volume and bottle format.
- Your model — third-party, franchise territory, or contract supply.
- Indicative quantity — an opening order range so they can map it to a minimum order quantity.
- Your papers — Drug License and GST; brand and trademark details if you’re labelling it yourself.
In return you should expect net rates, the minimum order quantity for that pack, lead times, and the validated packaging options — enough to commit to artwork and a first production run.
Sourcing Visiquin-LP from Biozia Lifesciences
Biozia Lifesciences manufactures the moxifloxacin + loteprednol combination as Visiquin-LP, one of an ophthalmic range that also includes drops such as Olopatadine. Established in 2025 and certified to WHO-GMP and ISO standards, the company runs sterile ophthalmic, injectable and IV-infusion lines alongside oral and herbal forms — 250+ formulations across nine dosage forms in total — from its base in Yamunanagar, Haryana, with pan-India supply. Its leadership, under Chairman Anil Kumar Goel, carries 40+ years in pharmaceuticals, which shows up where it counts for a buyer: dependable batch-to-batch sterile supply you can build a catalogue on.
Want this combination drop under your own brand or franchise? Request a manufacturing quote from Biozia Lifesciences →
Related guides
- Third-Party Pharma Manufacturing in India
- Linezolid Injection Manufacturer in India
- Paracetamol IV Infusion Manufacturer in India
- Olopatadine Eye Drops Manufacturer in India
Frequently asked questions
Can I get moxifloxacin + loteprednol drops under my own brand name?
Yes. Under a third-party arrangement the maker fills the drop to your specification and labels it with your brand, while they hold the sterile manufacturing licence. You keep the distribution and the margin. Biozia Lifesciences also offers this combination under its own Visiquin-LP brand for franchise partners.
Why can’t any contract manufacturer fill an eye drop?
Eye drops are sterile products applied to the eye, so they need aseptic filling lines with cleanrooms and validated controls — infrastructure many oral-dosage makers simply don’t have. That’s why proven ophthalmic capability should be your first qualifying question when shortlisting a supplier.
What dropper pack sizes are usually available?
Ophthalmic drops commonly come in LDPE dropper bottles of around 3 ml, 5 ml or 10 ml with a controlled-drop nozzle and tamper-evident cap. The exact validated formats depend on the manufacturer, so confirm the options before you commit to artwork.
What documents do I need to start sourcing?
A Drug License and GST registration are the essentials. If you’re putting your own label on the bottle, you’ll also need your brand name and trademark details, along with a clear pack and volume brief.
Does Biozia supply this drop across India?
Yes. Biozia Lifesciences manufactures from Yamunanagar, Haryana, and supplies pan-India through third-party, ophthalmic franchise and contract arrangements. Reach out via its contact page to discuss territory, pack and order terms.
Author: Biozia Lifesciences Editorial Team — insights drawn from Biozia Lifesciences’ WHO-GMP & ISO-certified manufacturing and PCD franchise operations in India, led by 40+ years of industry experience. This article is general business information and not medical or legal advice.
Interested in a Biozia PCD Franchise?
Get monopoly rights, a wide product range and full marketing support in your territory.